<DOC>
	<DOCNO>NCT02273661</DOCNO>
	<brief_summary>Compare incidence severe clinical exacerbation treatment ABPA , strategy maintenance treatment conventional strategy without antifungal maintenance therapy .</brief_summary>
	<brief_title>Evaluation Therapeutic Strategy Including Nebulised Liposomal Amphotericin B ( Ambisome® ) Maintenance Treatment Allergic Bronchopulmonary Aspergillosis ( Cystic Fibrosis Excluded ) .</brief_title>
	<detailed_description />
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Pulmonary Aspergillosis</mesh_term>
	<mesh_term>Aspergillosis , Allergic Bronchopulmonary</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<criteria>All patient ABPA justify attack treatment corticosteroid itraconazole combine follow criterion : 1. atopic subject history asthma , history total Immunoglobin E ( IgE ) &gt; 417 kU / L ( &gt; 210 kU / L clear worsening ) know ABPA ) , specific Immunoglobin E Aspergillus fumigatus positive ( &gt; 0.35 KUA/L ) positive skin test . 2. associated two follow criterion : documentation precipitate antibody Immunoglobulin G positive Aspergillus fumigatus , radiological infiltrates associate ABPA ( transitional / persistent / bronchial dilation ) , blood eosinophilia &gt; 500 elements/mm3 . 3 . After inform obtain consent sign . Women childbearing age effective contraception least 12 first month study ( 10 month + 2 month treatment washout ) pregnant lactate woman , Patient cystic fibrosis Patient contraindication itraconazole Intolerance β2 agonists Known hypersensitivity liposomal amphotericin B component Laboratory abnormality : significant abnormality platelet blood count , liver function test ( SGPT , SGOT ( serum glutamate oxaloacetate transaminase ) , total bilirubin &gt; 5 time upper limit normal range ) severe renal function impairment ( creatinine clearance enf 30 ml/min ) Concomitant use one follow treatment : Alfuzosine , alcaloïdes de l'ergot de seigle vasoconstricteur , aliskiren , astemizole , atorvastatine , avanafil , association Ombitasvir Paritaprevir , Bepridil , Cisaprid , Dabigatran , dapoxetin , domperidon , dronedaron , Eplerenone , Halofantrin , Ivabradin , Lomitapid , lurasidon , Millepertuis , mizolastin , Pimozid , Quétiapin , quinidin , Ranolazine , ritonavir , Sertindole , sildénafil , simvastatin , sirolimus , Sultoprid , Terfenadine , ticagrelor , triazolam Vardénafil ( men 75 ) patient anti IgE monoclonal antibody le 4 month current complication related previous treatment anti IgE monoclonal antibody Ventricular dysfunction demonstrate congestive heart failure history congestive heart failure Simple aspergilloma , chronic pulmonary aspergillosis , invasive pulmonary aspergillosis Respiratory infection aggravate asthma ABPA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>